Xeris Biopharma Holdings (XERS) Other Working Capital Changes (2020 - 2025)
Historic Other Working Capital Changes for Xeris Biopharma Holdings (XERS) over the last 6 years, with Q3 2025 value amounting to $5.2 million.
- Xeris Biopharma Holdings' Other Working Capital Changes rose 342451.61% to $5.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $3.6 million, marking a year-over-year increase of 5555.08%. This contributed to the annual value of $1.7 million for FY2024, which is 7780.58% down from last year.
- Per Xeris Biopharma Holdings' latest filing, its Other Working Capital Changes stood at $5.2 million for Q3 2025, which was up 342451.61% from -$270000.0 recorded in Q2 2025.
- In the past 5 years, Xeris Biopharma Holdings' Other Working Capital Changes registered a high of $5.2 million during Q3 2025, and its lowest value of -$3.7 million during Q4 2021.
- In the last 5 years, Xeris Biopharma Holdings' Other Working Capital Changes had a median value of $684000.0 in 2023 and averaged $692526.3.
- Its Other Working Capital Changes has fluctuated over the past 5 years, first tumbled by 154724.41% in 2021, then skyrocketed by 342451.61% in 2025.
- Over the past 5 years, Xeris Biopharma Holdings' Other Working Capital Changes (Quarter) stood at -$3.7 million in 2021, then soared by 130.71% to $1.1 million in 2022, then dropped by 20.9% to $893000.0 in 2023, then crashed by 71.89% to $251000.0 in 2024, then surged by 1952.99% to $5.2 million in 2025.
- Its last three reported values are $5.2 million in Q3 2025, -$270000.0 for Q2 2025, and -$1.5 million during Q1 2025.